MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection vial AUST R: 407050Active ingredients:
tirzepatide
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800 454 559
|
Deletion from market:
13 Jun 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by ARTG 439690 - MOUNJARO KwikPen tirzepatide 8.33 mg/mL solution for injection multidose pre-filled pen. More information about this discontinuation is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/discontinuation-mounjaro-tirzepatide-vials
|